A Letter to the Editor: “About 40,300 AEEs were reported in VAERS following COVID-19 vaccinations”
In the text, an example of possible real-world scale-up AEE numbers from VAERS entry numbers was provided; based on the assumptions used, a result of ~1,343,600 AEEs was obtained. It should be emphasized that scale-up from VAERS entry numbers to real-world numbers is unknown with any degree of accuracy at this point, but has the potential to result in large numbers of COVID-19 vaccine-induced AEEs (and subsequent reduced lifespans) over time.
Those AEE types that had the highest VAERS entry numbers were one-to-two orders-of-magnitude higher than their flu vaccine counterparts.
Tracking of AEEs cases over the next few years would help indicate any significant increases caused by the administration of the COVID-19 vaccines. Finally, the paucity or absence of human clinical trials before approval of the COVID-19 vaccines is completely incompatible with the potential for emergence of AEEs following COVID-19 vaccination, as indicated by the results in the present OpEd. Adequate pre-distribution testing for the COVID-19 vaccines may have been precluded by the legalistic framework established for Public Health Emergencies over the past five decades, as discussed in Appendix 1.
Dr. Ronald N. Kostoff